Rapid microfluidic assay for the detection of botulinum neurotoxin in animal sera

Toxins

Volumn 8, Issue 1, 2016, Pages

  Babrak, Lmar ^a   Lin, Alice ^a   Stanker, Larry H ^a   McGarvey, Jeffery ^a   Hnasko, Robert ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

Animal serum; Botulinum neurotoxin (BoNT); Botulism; Diagnostic; Immunoassay; Microfluidic; Rapid detection; Toxin

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; IMMOBILIZED ANTIBODY; NEUROTOXIN;

ANALYTICAL PARAMETERS; ARTICLE; AUTOMATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIMIT OF DETECTION; MICROFLUIDIC ANALYSIS; MICROPLATE READER; NONHUMAN; RAPID TEST; ROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; ANALYSIS; ANIMAL; BLOOD; BOVINE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FABACEAE; FRUIT AND VEGETABLE JUICE; HORSE; IMMUNOLOGY; MOUSE; PRESERVED FOOD; SERUM; SHEEP;

ANIMALS; ANTIBODIES, IMMOBILIZED; BOTULINUM TOXINS, TYPE A; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FABACEAE; FOOD, PRESERVED; FRUIT AND VEGETABLE JUICES; HORSES; HUMANS; LIMIT OF DETECTION; MICE; MICROFLUIDIC ANALYTICAL TECHNIQUES; NEUROTOXINS; SERUM; SHEEP;

EID: 84954435953     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins8010013     Document Type: Article

References (24)

1. Sobel, J. Botulism. Clin. Infect. Dis. 2005, 41, 1167-1173. [CrossRef] [PubMed]
2. Tighe, A.P.; Schiavo, G. Botulinum neurotoxins: Mechanism of action. Toxicon 2013, 67, 87-93. [CrossRef] [PubMed]
3. Dembek, Z.F.; Smith, L.A.; Rusnak, J.M. Botulism: Cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities. Disaster Med. Public Health Prep. 2007, 1, 122-134. [CrossRef] [PubMed]
4. Rossetto, O.; Pirazzini, M.; Montecucco, C. Botulinum neurotoxins: Genetic, structural and mechanistic insights. Nat. Rev. Microbiol. 2014, 12, 535-549. [CrossRef] [PubMed]
5. Burnett, J.C.; Henchal, E.A.; Schmaljohn, A.L.; Bavari, S. The evolving field of biodefence: Therapeutic developments and diagnostics. Nat. Rev. Drug Discov. 2005, 4, 281-297. [CrossRef] [PubMed]
6. Anniballi, F.; Fiore, A.; Lofstrom, C.; Skarin, H.; Auricchio, B.; Woudstra, C.; Bano, L.; Segerman, B.; Koene, M.; Baverud, V.; et al. Management of animal botulism outbreaks: From clinical suspicion to practical countermeasures to prevent or minimize outbreaks. Biosecur. Bioterror. 2013, 11, S191-S199. [CrossRef] [PubMed]
7. Ferreira, J.L. Comparison of amplified ELISA and mouse bioassay procedures for determination of botulinal toxins A, B, E, and F. J. AOAC Int. 2001, 84, 85-88. [PubMed]
8. Cai, S.; Singh, B.R.; Sharma, S. Botulism diagnostics: From clinical symptoms to in vitro assays. Crit. Rev. Microbiol. 2007, 33, 109-125. [CrossRef] [PubMed]
9. Ching, K.H.; Lin, A.; McGarvey, J.A.; Stanker, L.H.; Hnasko, R. Rapid and selective detection of botulinum neurotoxin serotype-A and -B with a single immunochromatographic test strip. J. Immunol. Methods 2012, 380, 23-29. [CrossRef] [PubMed]
10. Cheng, L.W.; Stanker, L.H. Detection of botulinum neurotoxin serotypes A and B using a chemiluminescent versus electrochemiluminescent immunoassay in food and serum. J. Agric. Food Chem. 2013, 61, 755-760. [CrossRef] [PubMed]
11. Singh, A.; Datta, S.; Sachdeva, A.; Maslanka, S.; Dykes, J.; Skinner, G.; Burr, D.; Whiting, R.C.; Sharma, S.K. Evaluation of an enzyme-linked immunosorbent assay (ELISA) kit for the detection of botulinum neurotoxins A, B, E, and F in selected food matrices. Health Secur. 2015, 13, 37-44. [PubMed]
12. Singh, A.K.; Stanker, L.H.; Sharma, S.K. Botulinum neurotoxin: Where are we with detection technologies? Crit. Rev. Microbiol. 2013, 39, 43-56. [CrossRef] [PubMed]
13. Stanker, L.H.; Merrill, P.; Scotcher, M.C.; Cheng, L.W. Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA. J. Immunol. Methods 2008, 336, 1-8. [CrossRef] [PubMed]
14. Butler, J.E. Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays. Methods 2000, 22, 4-23. [CrossRef] [PubMed]
15. Bompiani, K.M.; Dickerson, T.J. High-throughput screening technologies for botulinum neurotoxins. Curr. Top. Med. Chem. 2014, 14, 2062-2080. [CrossRef] [PubMed]
16. Rosow, L.K.; Strober, J.B. Infant botulism: Review and clinical update. Pediatr. Neurol. 2015, 52, 487-492. [CrossRef] [PubMed]
17. Arnon, S.S.; Schechter, R.; Inglesby, T.V.; Henderson, D.A.; Bartlett, J.G.; Ascher, M.S.; Eitzen, E.; Fine, A.D.; Hauer, J.; Layton, M.; et al. Botulinum toxin as a biological weapon: Medical and public health management. JAMA 2001, 285, 1059-1070. [CrossRef] [PubMed]
18. Whitesides, G.M. The origins and the future of microfluidics. Nature 2006, 442, 368-373. [CrossRef] [PubMed]
19. Baker, C.A.; Duong, C.T.; Grimley, A.; Roper, M.G. Recent advances in microfluidic detection systems. Bioanalysis 2009, 1, 967-975. [CrossRef] [PubMed]
20. Sanjay, S.T.; Fu, G.; Dou, M.; Xu, F.; Liu, R.; Qi, H.; Li, X. Biomarker detection for disease diagnosis using cost-effective microfluidic platforms. Analyst 2015, 140, 7062-7081. [CrossRef] [PubMed]
21. Jung, W.; Han, J.; Choi, J.; Ahn, C. Point-of-care testing (POCT) diagnostic systems using microfluidic lab-on-a-chip technologies. Microelectron. Eng. 2015, 132, 46-57. [CrossRef]
22. Zhang, Z.; Yu, L.; Xu, L.; Hu, X.; Li, P.; Zhang, Q.; Ding, X.; Feng, X. Biotoxin sensing in food and environment via microchip. Electrophoresis 2014, 35, 1547-1559. [CrossRef] [PubMed]
23. Scotcher, M.C.; Johnson, E.A.; Stanker, L.H. Characterization of the epitope region of F1-2 and F1-5, two monoclonal antibodies to botulinum neurotoxin type A. Hybridoma 2009, 28, 315-325. [CrossRef] [PubMed]
24. Scotcher, M.C.; McGarvey, J.A.; Johnson, E.A.; Stanker, L.H. Epitope characterization and variable region sequence of F1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type A (Hall strain). PLoS ONE 2009, 4. [CrossRef] [PubMed]